Paul Zogala is a partner at Murchinson, where he manages a portfolio of high-yield investments, including equities, convertible securities, debt instruments and warrants. In this role, he works closely with Murchinson’s private and public portfolio companies, and also sits on the board of one of Murchison’s acquired companies, Benuvia Therapeutics.
Paul joined Murchinson in 2014 as a senior trader, and soon rose to the position of portfolio manager. In 2022, he was named a partner of Murchinson.
Paul worked with Marc at another Toronto-based hedge fund prior to his career at Murchinson. Before that, he graduated with honors with a B.A. in Economics from McMaster University, and earned the designation of Chartered Market Technician. He is also a CFA Charter Holder.
Paul joined Murchinson in 2014 as a senior trader, and soon rose to the position of portfolio manager. In 2022, he was named a partner of Murchinson.
Paul worked with Marc at another Toronto-based hedge fund prior to his career at Murchinson. Before that, he graduated with honors with a B.A. in Economics from McMaster University, and earned the designation of Chartered Market Technician. He is also a CFA Charter Holder.
